FRA3B and other common fragile sites: The weakest links

Nature Reviews Cancer

Volumn 1, Issue 3, 2001, Pages 214-221

  Huebner, Kay ^a   Croce, Carlo M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID ANHYDRIDE HYDROLASE; FRAGILE HISTIDINE TRIAD PROTEIN; TUMOR PROTEIN;

ADULT; ALLELE; ANIMAL; APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHROMOSOME 3; CHROMOSOME 8; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITE; CHROMOSOME FRAGILITY; DNA REPLICATION; ESOPHAGUS TUMOR; FORECASTING; GASTROINTESTINAL TUMOR; GENE DELETION; GENE THERAPY; GENE TRANSLOCATION; GENETIC PREDISPOSITION; GENETIC RECOMBINATION; GENETICS; HUMAN; KIDNEY TUMOR; MOUSE; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN MOTIF; STRUCTURE ACTIVITY RELATION; TUMOR SUPPRESSOR GENE; ULTRASTRUCTURE;

ACID ANHYDRIDE HYDROLASES; ADULT; ALLELES; AMINO ACID MOTIFS; ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; CONSERVED SEQUENCE; DNA REPLICATION; ESOPHAGEAL NEOPLASMS; FORECASTING; GASTROINTESTINAL NEOPLASMS; GENE DELETION; GENE THERAPY; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY NEOPLASMS; MICE; MICE, KNOCKOUT; MODELS, GENETIC; NEOPLASM PROTEINS; RECOMBINATION, GENETIC; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSLOCATION, GENETIC;

EID: 0035753424     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/35106058     Document Type: Article

References (27)

1. Cohen, A. J. et al. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N. Engl. J. Med. 301, 592-595 (1979).
2. Glover, T. W., Berger, C., Coyle, J. & Echo, B. DNA polymerase-α inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet. 67, 136-142 (1984). Reports that the breaks and gaps induced by aphidicolin represent a new class of fragile sites: the common fragile sites.
3. Yunis, J. J. & Soreng, A. L. Constitutive fragile sites and cancer. Science 226, 1199-1204 (1984). Notes that locations of about half of the common fragile sites seem cytogenetically to coincide with locations of specific chromosome translocations that are associated with human cancers and might be near proto-oncogenes.
4. Ohta, M. et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84, 587-597 (1996). Reports the cloning of the FHIT gene, the t(3;8) translocation, the FRA3B fragile site and homozygous deletions in cancer cells.
5. Zimonjic, D. B. et al. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res. 57, 1166-1170 (1997).
6. Huebner, K., Sozzi, G., Brenner, C., Pierotti, M. A. & Croce, C. M. Fhit loss in lung cancer: diagnostic & therapeutic implications. Adv. Oncol. 15, 3-10 (1999).
7. Croce, C. M., Sozzi, G. & Huebner, K. Role of FHIT in human cancer. J. Clin. Oncol. 17, 1618-1624 (1999).
8. Siprashvili, Z. et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc. Natl Acad. Sci. USA 94, 13771-13776 (1997). The first report of suppression of cancer-cell tumorigenicity by overexpression of exogenous Fhit.
9. Sard, L. et al. The tumour-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc. Natl Acad. Sci. USA 96, 8489-8492 (1999).
10. Ji, L. et al. Induction of apoptosis and inhibition of tumorigenicity & tumour growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res. 59, 3333-3339 (1999). The first report of induction of apoptosis in cancer cells that are transfected with an adenovirus that encodes FHIT.
11. Richards, R. I. Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet. 17, 339-345 (2001).
12. Glover, T. W. in Genetic Instabilities and Neurological Diseases (eds Wells, R. D & Warren, S. T.) 75-83 (Academic, San Diego, 1998).
13. Kuwano, A. & Kajii, T. Synergistic effect of aphidicolin and ethanol on the induction of common fragile sites. Hum. Genet. 75, 75-78 (1987).
14. Dan, S., Cologne, J. B. & Nefushi, K. Effect of radiation and cigarette smoke on expression of FUdR-inducible common fragile sites in human peripheral lymphocytes. Mutat. Res. 334, 197-203 (1995).
15. Glover, T. W. & Stein, C. K. Chromosome breakage and recombination at fragile sites. Am. J. Hum. Genet. 43, 265-273 (1988).
16. Wang, N. D., Testa, J. R. & Smith, D.I. Determination of the specificity of aphidicolin-induced breakage of the human 3p14.2 fragile site. Genomics 17, 341-347 (1993).
17. Rassool, F. V. et al. Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites. Proc. Natl Acad. Sci. USA 88, 6657-6661 (1991).
18. Coquelle, A., Toledo, F., Stem, S., Bieth, A. & Debatisse, M. A new role for hypoxia in tumour progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs & HSRs. Mol. Cell 2, 259-265 (1998).
19. Inoue, H. et al. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. Proc. Natl Acad. Sci. USA 94, 14584-14589 (1997).
20. Mimori, K. et al. Cancer specific chromosome alterations in the constitutive fragile region, FRA3B. Proc. Natl Acad. Sci. USA 96, 7456-7461 (1999).
21. Mishmar, D. et al. Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc. Natl Acad. Sci. USA 95, 8141-6146 (1998). Reports cloning and characterization of FRA7H.
22. Huang, H. et al. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer. Genes Chromosom. Cancer 24, 48-55 (1999).
23. Tatarelli, C., Linnenbach, A., Mimori, K. & Croce, C. M. Characterization of the human testin gene localized in the FRA7G region at 7q31.2. Genomics 68, 1-12 (2000). References 22 and 23 report the cloning and partial characterization of FRA7G.
24. Ried, K. et al. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum. Mol. Genet. 9, 1651-1663 (2000).
25. Artt, M. F., Miller, D. E. Beer, D. G. & Glover, T. W. Molecular characterization of FRAXB and comparative common fragile ate instability in cancer cells. Genes Chromosom. Cancer 33, 82-92 (2002). Identification and sequencing of the FRAXB region, and characterization of deletions in FRAXB in oesophageal cancer cells.
26. Glover, T. W. et al. The murine Fhit gene is highly similar to its human ortholog and maps to a common fragile site region. Cancer Res. 58, 3409-3414 (1998). Reports that the mouse orthologue of Fhit also encompasses a fragile site: Fra14A2.
27. Shiraishi, T. et al. Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit. Proc. Natl Acad. Sci. USA 98, 5722-5727 (2001).